MetLife Investment Advisors LLC purchased a new position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 71,065 shares of the medical instruments supplier’s stock, valued at approximately $4,678,000.
Several other large investors also recently bought and sold shares of XRAY. Generation Investment Management LLP boosted its position in shares of DENTSPLY SIRONA by 115.6% in the 4th quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock worth $593,238,000 after purchasing an additional 4,831,112 shares during the last quarter. Viking Global Investors LP boosted its position in shares of DENTSPLY SIRONA by 51.9% in the 4th quarter. Viking Global Investors LP now owns 5,397,707 shares of the medical instruments supplier’s stock worth $355,331,000 after purchasing an additional 1,844,190 shares during the last quarter. Alyeska Investment Group L.P. boosted its position in shares of DENTSPLY SIRONA by 223.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock worth $135,860,000 after purchasing an additional 1,569,746 shares during the last quarter. Frontier Capital Management Co. LLC bought a new position in shares of DENTSPLY SIRONA in the 4th quarter worth $60,449,000. Finally, Jackson Square Partners LLC boosted its position in shares of DENTSPLY SIRONA by 15.6% in the 3rd quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock worth $378,890,000 after purchasing an additional 855,199 shares during the last quarter. Institutional investors and hedge funds own 96.80% of the company’s stock.
Several research firms have recently issued reports on XRAY. Barclays began coverage on DENTSPLY SIRONA in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price target on the stock. JPMorgan Chase & Co. reduced their price target on DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating on the stock in a research report on Monday, March 5th. Barrington Research reiterated an “outperform” rating and set a $70.00 target price (down from $73.00) on shares of DENTSPLY SIRONA in a report on Monday, March 5th. HC Wainwright set a $63.00 target price on DENTSPLY SIRONA and gave the stock a “hold” rating in a report on Monday, March 5th. Finally, Credit Suisse Group reduced their target price on DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating on the stock in a report on Friday, March 2nd. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $67.43.
DENTSPLY SIRONA Inc (NASDAQ:XRAY) opened at $50.71 on Monday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.45 and a current ratio of 2.10. The firm has a market capitalization of $11,530.19, a PE ratio of -7.37, a price-to-earnings-growth ratio of 2.21 and a beta of 1.21. DENTSPLY SIRONA Inc has a twelve month low of $50.62 and a twelve month high of $68.98.
DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.01. The firm had revenue of $1.09 billion for the quarter, compared to analyst estimates of $1.06 billion. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.67 earnings per share. equities analysts predict that DENTSPLY SIRONA Inc will post 2.75 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Friday, April 13th. Stockholders of record on Thursday, March 29th will be issued a $0.0875 dividend. The ex-dividend date is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.69%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -5.09%.
COPYRIGHT VIOLATION WARNING: This news story was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3301834/metlife-investment-advisors-llc-invests-4-68-million-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.